LCTX
Lineage Cell Therapeutics, Inc. · Healthcare
Broadwood Partners, L.P. bought $6.0M of Lineage Cell Therapeutics, Inc.
Director and 10% owner
Bought$6,000,000
$0.76Price
7,894,737Shares
+9%Stake
What LCTX did for a copier
- $1,000 copied at Wed, Jan 29 open, $0.68
- $765
- S&P 500, same days
- −8.7%
Measured over 30 trading days, to the Mar 13 close.
Broadwood Partners, L.P.'s record
28 other buys with 3 months of prices since 2018: on average −0.9% against the S&P 500, and 12 of 28 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Mon, Jan 27. Filed Tue, Jan 28, 7:49 PM ET, after the close. Returns use the Jan 29 open and the Mar 13 close. Not investment advice.